Clik here to view.
Gamesmanship in GIK valuations? Part 1
Forbes magazine dives into the nonprofit community’s GIK valuation issue in an article by William P. Barrett, Donated Pills Make Some Charities Look Too Good On Paper. (In print the article had a...
View ArticleClik here to view.
Impact of changing rules for determining fair value (SFAS 157) on GIK of NPOs
Wow. When I started blogging about GIK valuations, I knew there was a major issue, but didn’t quite grasp how big it really is. The beginning point of my discussion was a Forbes article, by William P....
View ArticleClik here to view.
Unintended consequences – - how much harm can doing good cause?
What in the world is Swedow? In writing about GIK and deworming meds, I’ve learned some fancy words, like Albendazole, Mebendazole and Swedow. I’ve also started reading discussions in places I usually...
View ArticleClik here to view.
Impact on GIK values form change in accounting rules – Part 4 – A few final...
Previously I’ve discussed the impact of new accounting rules on valuing of deworming medicine. Have been looking at Feed the Children financial statements to quantify the impact. I am not picking on...
View ArticleClik here to view.
Guidance on valuing medical GIKs in the 2011 NPO Audit Risk Alert
The issue of determining fair value of donated pharmaceuticals has been quiet for a little while. I’ve not seen much discussion of mebendazole on the ‘net lately. Perhaps it is safe to venture back...
View ArticleClik here to view.
World Vision posts pro forma adjustment which drops combined total revenue...
World Vision has posted their 2012 financial information. You can find the information on this page. The audited financial statements are here. Included on that page is another document, Charity...
View ArticleClik here to view.
Article on GIK valuation in Journal of Accountancy
“Gifts-in-kind: What are they worth? How to avoid pitfalls of GIK valuation” discusses the difficulties in valuing GIKs. The article is available online from the Journal of Accountancy. The author is...
View ArticleClik here to view.
Something missing from the Journal of Accountancy article on GIK
William Barrett points out there was some missing disclosure in the JofA article on GIK in his post Seattle-area charity scores P.R. coup from lack of disclosure. I discussed the JofA article here. The...
View ArticleClik here to view.
How do you keep one person from diverting funds and causing a front-page...
How do you keep one person from creating a public relations fiasco or, even worse, damaging the reputation of your entire organization? How do you keep a manager from illegally diverting a huge amount...
View ArticleClik here to view.
Initial reaction to alleged diversion of World Vision funds
Last week, the Israeli intelligence service accused a World Vision manager of diverting resources to Hamas. The allegation is he diverted about 60% of the annual funds flowing through the Gaza office,...
View ArticleClik here to view.
After reading about the mess World Vision is in, ask yourself what you are...
A few articles to follow up on the accusations a World Vision manager allegedly routed aid money to a terrorist organization. Looks like the situation with the Gaza branch of World Vision could turn...
View ArticleWorld Vision withdraws opposition to AB 1181. Other changes in list of those...
World Vision is now neutral on AB 1181. Three of the five analyses prepared for AB 1181 contain a list of the organizations supporting and opposing the legislation. A comparison of the lists shows key...
View ArticleUnintended consequences –– how much harm can doing good cause?
What in the world is Swedow? In writing about GIK and deworming meds, I’ve learned some fancy words, like Albendazole, Mebendazole and Swedow. I’ve also started reading discussions in places I usually...
View ArticleClik here to view.
Impact on GIK values form change in accounting rules – Part 4 – A few final...
Previously I’ve discussed the impact of new accounting rules on valuing of deworming medicine. Have been looking at Feed the Children financial statements to quantify the impact. I am not picking on...
View ArticleGuidance on valuing medical GIKs in the 2011 NPO Audit Risk Alert
The issue of determining fair value of donated pharmaceuticals has been quiet for a little while. I’ve not seen much discussion of mebendazole on the ‘net lately. Perhaps it is safe to venture back...
View Article
